| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Bitterman Kevin is a Director at Editas Medicine, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $8.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 12,819 | $15.77 | $202,155.63 | -0.3% | |
| Nov 16, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 30,830 | $16.30 | $502,529.00 | -0.8% | |
| Nov 15, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 88,900 | $16.96 | $1,507,308.89 | -0.7% | |
| Sep 8, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 500,000 | $16.80 | $8,400,000.00 | -10.7% |